| Item Type | Name |
|
Concept
|
Heart Atria
|
|
Concept
|
Heart Valve Prosthesis
|
|
Concept
|
Heart Arrest
|
|
Concept
|
Heart Conduction System
|
|
Concept
|
Heart
|
|
Concept
|
Heart Septal Defects, Atrial
|
|
Concept
|
Heart Ventricles
|
|
Concept
|
Heart Failure
|
|
Concept
|
Heart Valve Diseases
|
|
Concept
|
Heart Diseases
|
|
Concept
|
Heart Rate
|
|
Academic Article
|
Enhancement of myocardial vulnerability by atrial fibrillation.
|
|
Academic Article
|
The pharmacologic treatment of heart failure.
|
|
Academic Article
|
Nesiritide: the wrong controversy.
|
|
Academic Article
|
Patent foramen ovale closure devices: thoughts from the circulatory device advisory panel.
|
|
Academic Article
|
Flecainide: safety and efficacy.
|
|
Academic Article
|
The cholesterol hypothesis: questioned?
|
|
Academic Article
|
QT dispersion: still a useful measurement.
|
|
Academic Article
|
The management of acute heart failure and diuretic therapy.
|
|
Academic Article
|
Therapeutic approaches to the treatment of edema and ascites: the use of diuretics.
|
|
Academic Article
|
The clinical pharmacology of ethacrynic acid.
|
|
Academic Article
|
QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol.
|
|
Academic Article
|
The impact of comorbidities on stroke prophylaxis strategies in atrial fibrillation patients.
|
|
Academic Article
|
Courts, patents, litigation & patient care.
|
|
Academic Article
|
A Rapid Method to Evaluate Cardiac Repolarization Changes: The Effect of Two Coffee Strengths on the QT Interval.
|
|
Academic Article
|
Angiotensin-Neprilysin Combinations Marketing Poly or Therapeutic Optimization.
|
|
Academic Article
|
Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual.
|
|
Academic Article
|
The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat.
|
|
Academic Article
|
Neural basis for the genesis and control of digitalis arrhythmias.
|
|
Academic Article
|
Role of the nervous system in the genesis of cardiac rhythm disorders.
|
|
Academic Article
|
A comparison of tablets with oral suspension formulation of dipyridamole in thallium myocardial imaging.
|
|
Academic Article
|
Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
|
|
Academic Article
|
The treatment of ventricular rhythm disturbances.
|
|
Academic Article
|
Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
|
|
Academic Article
|
Antiarrhythmic drug therapy. Recent advances and current status.
|
|
Academic Article
|
Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide.
|
|
Academic Article
|
Encainide: a new and potent antiarrhythmic.
|
|
Academic Article
|
Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
|
|
Academic Article
|
Supraventricular tachyarrhythmias: their evaluation and therapy.
|
|
Academic Article
|
The antiarrhythmic effects of d-sotalol.
|
|
Academic Article
|
Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
|
|
Academic Article
|
Refractory ventricular tachycardia with flecainide.
|
|
Academic Article
|
Prolongation of QT interval and antiarrhythmic action of bepridil.
|
|
Academic Article
|
Long term lorcainide therapy guided by electrophysiology studies.
|
|
Academic Article
|
Therapy for late post infarction ventricular tachycardia.
|
|
Academic Article
|
QT prolongation and the antiarrhythmic efficacy of amiodarone.
|
|
Academic Article
|
Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide.
|
|
Academic Article
|
Lorcainide therapy in a cardiac arrest population.
|
|
Academic Article
|
Long-term lorcainide therapy in patients with ventricular tachycardia.
|
|
Academic Article
|
Prolonged repolarization: a historical perspective.
|
|
Academic Article
|
Flecainide: long-term treatment using a reduced dosing schedule.
|
|
Academic Article
|
Antiarrhythmic effects of cibenzoline.
|
|
Academic Article
|
The arrhythmogenicity of antiarrhythmic agents.
|
|
Academic Article
|
The clinical significance of polymorphic ventricular tachycardia provoked at electrophysiologic testing.
|
|
Academic Article
|
The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity.
|
|
Academic Article
|
The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
|
|
Academic Article
|
Antiarrhythmic action of bethanidine.
|
|
Academic Article
|
Lorcainide therapy for the high-risk patient post myocardial infarction.
|
|
Academic Article
|
Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
|
|
Academic Article
|
Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia.
|
|
Academic Article
|
The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog.
|
|
Academic Article
|
Effect of quinidine on differing sensitivities of Purkinje fibers and myocardium to inhibition of monovalent cation transport by digitalis in dogs.
|
|
Academic Article
|
Flecainide toxicity.
|
|
Academic Article
|
Cibenzoline plasma concentration and antiarrhythmic effect.
|
|
Academic Article
|
Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate.
|
|
Academic Article
|
Can nitroglycerin convert effort-induced angina in men into silent myocardial ischemia?
|
|
Academic Article
|
Proarrhythmia: definition, risk factors, causes, treatment, and controversies.
|
|
Academic Article
|
Proarrhythmia of nonantiarrhythmic drugs.
|
|
Academic Article
|
Successful heart failure therapy is effective antiarrhythmia therapy.
|
|
Academic Article
|
QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in a twenty-four-hour assessment.
|
|
Academic Article
|
Effect of intracoronary balloon inflation at percutaneous transluminal coronary angioplasty on QT dispersion.
|
|
Academic Article
|
Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators.
|
|
Academic Article
|
Clinical therapeutic conference: congestive heart failure therapy.
|
|
Academic Article
|
Is the evidence right in evidence-based practice?
|
|
Academic Article
|
Effect of angiotensin-converting enzyme therapy on QT interval dispersion.
|
|
Academic Article
|
Atrial fibrillation and valve disease.
|
|
Academic Article
|
Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect.
|
|
Academic Article
|
Heart Failure Research and Polypharmacy.
|